Angioimmunoblastic T-Cell Lymphoma.
Angioimmunoblastic T-cell lymphoma
Follicular helper T-cell
Pathology
Treatment
Journal
Cancer treatment and research
ISSN: 0927-3042
Titre abrégé: Cancer Treat Res
Pays: United States
ID NLM: 8008541
Informations de publication
Date de publication:
Historique:
entrez:
1
1
2019
pubmed:
1
1
2019
medline:
2
7
2019
Statut:
ppublish
Résumé
Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15-20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features. Classes of drugs particularly active in AITL are emerging; however, treatment of relapsed and refractory disease remains a challenge. This chapter reviews the epidemiology, clinical presentation, pathogenesis, diagnosis, and treatment of AITL.
Identifiants
pubmed: 30596215
doi: 10.1007/978-3-319-99716-2_5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM